Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Hematology
Volume 47, Issue 2, Pages 105-210 (April 2010)
Search Within This Issue
Rituximab
Edited by Adrian Wiestner MD, PhD

display abstract citation download email a colleague
Display:

free full text =free full text


Rituximab: Therapeutic Benefit! Vitamin R?
Clifton Mo, Berengere Vire, Adrian Wiestner
pages 105-106
Full Text | Full-Text PDF (87 KB)


CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
Stephen A. Beers, Claude H.T. Chan, Ruth R. French, Mark S. Cragg, Martin J. Glennie
pages 107-114
Abstract | Full Text | Full-Text PDF (667 KB)


Rituximab: Mechanism of Action
George J. Weiner
pages 115-123
Abstract | Full Text | Full-Text PDF (594 KB)


Antigenic Modulation and Rituximab Resistance
Ronald P. Taylor, Margaret A. Lindorfer
pages 124-132
Abstract | Full Text | Full-Text PDF (247 KB)


Rituximab in Indolent Lymphomas
Tarek Sousou, Jonathan Friedberg
pages 133-142
Abstract | Full Text | Full-Text PDF (489 KB)


Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab
Michael Bennett, Geraldine P. Schechter
pages 143-147
Abstract | Full Text | Full-Text PDF (162 KB)


Rituximab in High-Grade Lymphoma
Carsten Zwick, Niels Murawski, Michael Pfreundschuh, German High-Grade Non-Hodgkin Lymphoma Study Group
pages 148-155
Abstract | Full Text | Full-Text PDF (510 KB)


Rituximab in Chronic Lymphocytic Leukemia
Samantha M. Jaglowski, John C. Byrd
pages 156-169
Abstract | Full Text | Full-Text PDF (386 KB)


Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells
Roberto Stasi
pages 170-179
Abstract | Full Text | Full-Text PDF (445 KB)


Rituximab-Associated Neutropenia
Kieron Dunleavy, Kevin Tay, Wyndham H. Wilson
pages 180-186
Abstract | Full Text | Full-Text PDF (404 KB)


Rituximab-Associated Infections
Juan C. Gea-Banacloche
pages 187-198
Abstract | Full Text | Full-Text PDF (339 KB)


CD20-Targeted Therapy: The Next Generation of Antibodies
Tom van Meerten, Anton Hagenbeek
pages 199-210
Abstract | Full Text | Full-Text PDF (879 KB)

Frontmatter


Table of Contents free full text
pages A5-A6
Full-Text PDF (28 KB)


Future Issues and Recent Issues free full text
page A10
Full-Text PDF (24 KB)

display abstract citation download email a colleague
Display:
Advertisement